BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2350918)

  • 1. HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.
    Esteban F; Ruiz-Cabello F; Concha A; Pérez-Ayala M; Sánchez-Rozas JA; Garrido F
    Clin Exp Metastasis; 1990; 8(4):319-28. PubMed ID: 2350918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of host immune response and apoptosis in patients with laryngeal squamous cell carcinoma.
    Gomatos IP; Georgiou A; Giotakis J; Manolopoulos L; Apostolou K; Chatzigianni E; Albanopoulos K; Ferekidou E
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):159-66. PubMed ID: 17264532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic characterization of medullary carcinoma of the breast: HLA-DR expression in lymph node positive cases.
    Lazzaro B; Anderson AE; Kajdacsy-Balla A; Hessner MJ
    Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):234-41. PubMed ID: 11556751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
    Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
    Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells in precancerous lesions of the larynx.
    Sprinzl GM; Hussl B; Obrist P; Yoneda K; Thumfart WF; Romani N; Schrott-Fischer A
    Laryngoscope; 2000 Jan; 110(1):13-8. PubMed ID: 10646708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of HLA DR expression and lymphocytic infiltrate in laryngeal cancer including clinical and morphological correlations.
    Sikorska B; Danilewicz M; Wagrowska-Danilewicz M
    Gen Diagn Pathol; 1998 Apr; 143(5-6):297-303. PubMed ID: 9653911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites.
    Mattijssen V; De Mulder PH; Schalkwijk L; Manni JJ; Van 't Hof-Grootenboer B; Ruiter DJ
    Int J Cancer Suppl; 1991; 6():95-100. PubMed ID: 2066187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR expression is a significant prognostic factor in laryngeal cancer. A morphometric study.
    Sikorska B; Danilewicz M; Wagrowska-Danilewicz M
    APMIS; 1999 Apr; 107(4):383-8. PubMed ID: 10230691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research into the human leucocyte antigen I deletion and local lymphocytes infiltration in laryngeal carcinoma].
    Niu C; Liu X; Zhou W; Jing L; Du B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Jun; 37(3):215-8. PubMed ID: 12772327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of HLA-DR antigen on head and neck carcinomas--immunohistological study].
    Samukawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1993 Jan; 96(1):88-97. PubMed ID: 8459313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
    Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
    Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR antigen expression in squamous epithelial dysplasia and squamous cell carcinoma of the esophagus: an immunohistochemical study.
    Sumiyoshi K; Kuwano H; Watanabe M; Kitamura M; Toh Y; Sugimachi K
    Oncol Rep; 1999; 6(2):301-6. PubMed ID: 10022993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators.
    Georgiannos SN; Renaut A; Goode AW; Sheaff M
    Surgery; 2003 Nov; 134(5):827-34. PubMed ID: 14639362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice.
    Kawai K; Resetkova E; Enomoto T; Fornasier V; Volpé R
    J Clin Endocrinol Metab; 1998 Jan; 83(1):157-64. PubMed ID: 9435434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx.
    Esteban F; Concha A; Delgado M; Pérez-Ayala M; Ruiz-Cabello F; Garrido F
    Br J Cancer; 1990 Dec; 62(6):1047-51. PubMed ID: 2257212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA-class II antigen in gastric carcinomas. Its relationship to histopathological grade, lymphocyte infiltration and five-year survival rate.
    Ma XC; Hattori T; Kushima R; Terata N; Kodama M
    Acta Oncol; 1994; 33(2):187-90. PubMed ID: 8204274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. II. Clinicopathologic correlations with the loss of expression of the HLA ABC antigens].
    Esteban F; Concha A; Delgado M; Ruiz-Cabello F; Garrido F
    Acta Otorrinolaringol Esp; 1990; 41(6):359-68. PubMed ID: 2092725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.